Our Mission

Provide an evaluation, a factual and independent opinion
on key issue or strategy proposed by a company, reporting strategic information in all sincerity, loyalty and transparency.

To certify that all the information provided during an audit is present in an expected final report.

Reveal the immaterial value of companies, validate the viability of an industrial project, estimate and validate the medical demand.

For who ?

For any prescriber, adviser, buyer, or seller of a company

  • Financial experts
  • Contributions auditor
  • Statutory Auditor
  • Executive board
  • Law office
  • ...

We intervene

Before any financial transaction

  • In the processes of balance sheet analysis
  • Goodwill - estimating the tangible and intangible value of a company
  • Before shareholding reorganization
  • Before a fundraiser
  • Business co-operation
  • Business transfer
  • Listing on the stock exchange
  • LBO, LBI or M & A
  • Spin-off etc ...

Our key added values

As hunter and revealer of values ​​and assets

A pioneer in asset valuation and non-accounting analysis of health business models, Mayakare agency contributes to improving methods for evaluating business performance.

More values : our firm was created with a unique value proposition to provide a robust holistic approach in transaction services, combining a triple skill implementing medical, financial and extra-financial accounting expertise.

More Confidence : Over the past five years, we have won the trust of our customers, with the highest expectations, and have successfully set a new standard and new good due diligence practice that fits any size from the start-up to the listed company.

More input : by building on this triple vision to go beyond raw analysis and put more human in the data set, while giving recommendations and helping our customers to implement them in the post-deal context.

More perspective : thanks to the skills of our talents and our internal methodology, we are convinced that we are helping to adopt and build new benchmarks thanks to a deep understanding of emerging economic models in health.

Expertise

MayaKare intervenes in France, Geneva, Quebec, Belgium, Monaco, Luxembourg...

Sectoral expertise

Medical device - Medtech

  • Medical equipment
  • Medical instrument
  • Surgical equipment
  • Surgical instrument
  • Medical examination material
  • Medical examination instrument
  • Medical prosthese
  • Medical device Class I : non-invasive
  • Medical device Class IIa : Invasive
  • Medical device Class IIa : implantable
  • Medical device Class III : implantable and active

Connected medical device – E-Health

  • Digital Diagnostics
  • Computer Assisted Digital Diagnostics
  • Telemedicine
  • Connected object
  • Patient telemonitoring system - Real time patient telemonitoring system
  • Medical application – medicalapp - Medical application mobil

Other

  • Biocleantechs
  • Biogreentech

Opérational expertise

  • Oncology
  • Radiotherapy, radiation therapy
  • Medical imaging
  • Infectiology
  • Chronic Diseases
  • Nutrition

Our References

Our Partners

Awards

After a rigorous procedure of internal verification of information about Mayakare, supplemented by an external data analysis ; the GHP jury rewarded Mayakare because it fulfills a mission of the type "great contribution to the global Medtech industry".

His contribution to the GHP jury eyes is therefore remarkable on the following criteria:

  • pioneer in the implementation of extra-accounting analysis of healthcare business models in Europe.
  • contributes to improving methods for evaluating the performance of companies in the medical technology sector,
  • contributes to the economic longevity of the Medtech sector by specializing in the analysis of medical innovations,
  • offers an approach that promotes the continuous growth of its customers,
  • ensures a mission that improves the longevity of the business models of these customers,
  • to offer a service that integrates the end of the value chain: the medical service provided to patients and patients.

Testimonials

Mayakare propose une solution unique, c’est un réel facilitateur pour permettre aux fabricants d’identifier les facteurs de réussite au développement et d’assurer leur financement. C’est un tiers de confiance bienveillant entre les financeurs et les fabricants

Fabrice Romano, Président de Keranova

L'analyse nous a conforté dans nos forces et axes d'amélioration et Mayakare n'a pas hésité à faire jouer son carnet d'adresse pour accélérer nos recherches. Beaucoup de choses sont couvertes dans l'analyse sur l’équipe et le fond du projet. Gardez ce professionnalisme qui est un vrai atout

Julien Gillet Daubin, Fondateur et Directeur général de Neolys Diagnostics

La lecture de l’image donnée par l’audit est réaliste et lisible instantanément. La méthode d’analyse est solide, elle débouche sur des résultats concrets mesurables et comparables. Mais surtout cette méthode adapte ses propres critères à l’innovation évaluée et elle s’attache à la situer dans les tendances futures, sans uniquement se concentrer sur l’historique du secteur visé. Elle permet avec ses outils puissants d’analyse, de situer avec pertinence l’innovation dans les tendances futures

Olivier Goulay Vice Président Elicit Plant

La notation extra financière réalisée par Mayakare m’a aidée à prendre conscience et à exprimer de manière simple et forte l'acquis et la projection du Laboratoire BeePratte. Stéphanie Patin fondatrice de MayaKare, a su extraire de la montagne d'information que nous avons fournie ce qui fait l'essentiel de notre innovation et des valeurs qui la sous-tendent

Josette Pratte, PDG Laboratoire Beepratte